Category:21st Century Cures Act: Difference between revisions
Jump to navigation
Jump to search
(Adding Dan Burton lobbying target) |
(added cquote) |
||
Line 1: | Line 1: | ||
{{cquote|The 21st Century Cures Act is a bipartisan bill that would reform the current standards and appropriations for biomedical research, provide $1.75 billion annually for the National Institutes of Health (NIH) and $110 million for the Food and Drug Administration (FDA).}} |
|||
==See also== |
==See also== |
||
*[http://www.modernhealthcare.com/article/20160119/NEWS/160119845 Senate won't take up House's 21st Century Cures Act] |
*[http://www.modernhealthcare.com/article/20160119/NEWS/160119845 Senate won't take up House's 21st Century Cures Act] |
Revision as of 14:38, 8 August 2016
“ | The 21st Century Cures Act is a bipartisan bill that would reform the current standards and appropriations for biomedical research, provide $1.75 billion annually for the National Institutes of Health (NIH) and $110 million for the Food and Drug Administration (FDA). | ” |
See also
- Senate won't take up House's 21st Century Cures Act
- Chairman Alexander Announces Committee Schedule for “Step by Step” Consideration of Biomedical Innovation Bills
External links
H.R. 6 (114th): 21st Century Cures Act, GovTrack. Passed the House with overwhelming bipartisan support, assigned to Senate Committee who opted to pursue alternative legislation.
Pages in category "21st Century Cures Act"
The following 4 pages are in this category, out of 4 total.